In this blog, we share with you our analysis of the cancer research market size, trends and key players for ELISA Kits and research antibodies. We uncover the three dominant leaders for each reagent type, and one supplier who appears in the top three in both markets. If you’re interested...
We have noticed a number of other top 10 companies making gains in the cancer research market (share value is determined by % of citations from CiteAb market data). Abcam now claims a strong 25% market share, up from 16.7% in 2016. This is impressive growth, and perhaps not surprising ...
“Through this transaction, we will be able to harness the full potential of our precision oncology platform to advance the standard of care for cancer patients. Since our founding, we have leveraged our deep scientific expertise to develop a pipeline of promising pr...
Janssen Research & Development, LLC, one of the Janssen Pharmaceutical Companies of Johnson & Johnson and one of the world’s leaders in oncology, is focused on harnessing the most compelling science with the aim of intercepting, preventing, treating, and ultimately curing cancer. Working toward t...
Focusing on three fields: the Environment, Resilience, and Security & Safety Hitachi has always strived to improve people's quality of life and increase value for partner companies by making maximum use of its strengths in "OT x IT x Products" and offering consumer-centric digital solutions ...
Credit: Cancer Hospital, Chinese Academy of Medical Sciences How is China progressing in anti-cancer drug research? Cancer is a leading cause of death in China. According to the latest data from NCC, there are an estimated 3.93 million new cancer cases, and nearly 2.34 million cancer deaths ...
Clario is one of the world’s most successful medical research companies, and cutting-edge biotech brands. For over 50 years, the company has been a critical player among leading biotech firms, helping to unlock new discoveries and create world-changing medical devices. ...
Mölnlycke is owned by Patricia Industries AB, which is part of Investor AB, an engaged owner of high-quality, global companies founded by the Wallenberg family in 1916. www.molnlycke.com 17/3/2025 Mölnlycke Health Care announces launch of the 2025 Future Summit “At Mölnlycke, we ...
With Leading Global Companies to Remove Workplace Barriers to Preventive Care Research reveals 20 million US workers neglect to use time off from work for cancer screening; up to 100,000 American lives could be saved annually through advanced screening efforts1 ...
Foundation Medicine is a world-leading molecular insights company, connecting physicians, patients and biopharma partners to the latest insights in cancer genomics. Learn more.